comprehensive -WSS

comprehensive

author：hotspot 2025-09-28 02:29:55 - browse：3

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： HHS secretary Becerra pressed on Change HealthCare cyberattack

entertainment

WSS

Ozempic has benefits for kidney disease as well as diabetes

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Readout Newsletter: CAR

Lack of health data on LGBTQ+ people has serious consequences

Immune cells and nerve overgrowth may explain recurring UTI pain

Wikipedia

comprehensive

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

explore

Dobbs anniversary: the lost opportunity of abortion as health care

WuXi out of biotech trade group, U.S. and China relations to blame

Trump demands the U.S. pay no more for drugs than other countries … again

How many hemophilia patients actually want gene therapy?

DIEP, the 'gold standard' of breast reconstruction, is under threat

State of the Union pitch: Bigger Medicare drug price negotiations

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

$1 billion proposal to grow Boston, Massachusetts biotech

Wikipedia

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

The untold story of TV’s first prescription drug ad

Why depression after traumatic brain injury is distinct

Change Healthcare: What is it, why does its cyberattack matter?

Microsoft's Peter Lee: Generative AI could help doctors be more human

Ancient Greek ideas underpin modern concepts of pregnancy

entertainment

entertainment

leisure time

Wikipedia